DD260494A5 - Verfahren zur herstellung von alpha-hydroxythiotherm - Google Patents

Verfahren zur herstellung von alpha-hydroxythiotherm Download PDF

Info

Publication number
DD260494A5
DD260494A5 DD86297075A DD29707586A DD260494A5 DD 260494 A5 DD260494 A5 DD 260494A5 DD 86297075 A DD86297075 A DD 86297075A DD 29707586 A DD29707586 A DD 29707586A DD 260494 A5 DD260494 A5 DD 260494A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
acid
group
radical
Prior art date
Application number
DD86297075A
Other languages
German (de)
English (en)
Inventor
Andreas Beck
Werner Breitenstein
Andreas Von Sprecher
Robert W Lang
Konrad Oertle
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD260494A5 publication Critical patent/DD260494A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
DD86297075A 1985-12-06 1986-12-04 Verfahren zur herstellung von alpha-hydroxythiotherm DD260494A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH522885 1985-12-06

Publications (1)

Publication Number Publication Date
DD260494A5 true DD260494A5 (de) 1988-09-28

Family

ID=4290092

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86297075A DD260494A5 (de) 1985-12-06 1986-12-04 Verfahren zur herstellung von alpha-hydroxythiotherm

Country Status (17)

Country Link
US (1) US4808572A (ja)
EP (1) EP0225602B1 (ja)
JP (1) JPS62138465A (ja)
AT (1) ATE68177T1 (ja)
AU (1) AU6613886A (ja)
CA (1) CA1303294C (ja)
DD (1) DD260494A5 (ja)
DE (1) DE3681890D1 (ja)
DK (1) DK586186A (ja)
ES (1) ES2040205T3 (ja)
FI (1) FI864901A (ja)
GR (1) GR3003066T3 (ja)
HU (1) HU196173B (ja)
IL (1) IL80866A0 (ja)
NO (1) NO864896L (ja)
PT (1) PT83868B (ja)
ZA (1) ZA869213B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
FR2648814B1 (fr) * 1989-06-26 1991-10-18 Lafon Labor L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
DE59410387D1 (de) * 1993-01-29 2004-10-21 Ticona Gmbh Faserverstärktes Cycloolefincopolymer-Material, Verfahren zu seiner Herstellung und Formkörper aus dem Material
EP1689698A4 (en) * 2003-11-13 2007-09-05 Univ Sydney BISCATION COMPOUNDS AND THEIR APPLICATION
WO2007022718A1 (en) * 2005-08-25 2007-03-01 Chunde Liu Alkyl aryl alkyl alcohols, their derivations and preparation process thereof
MX2013004649A (es) 2010-10-28 2013-06-05 Mapi Pharma Ltd Compuestos intermedios y proceso para la preparacion de fingolimod.
CN102850319A (zh) * 2011-06-27 2013-01-02 中国药科大学 一种制备{5-[2-(4-正辛基苯基)乙基]-2,2-二甲基-1,3-二氧六环-5-基}氨基甲酸叔丁酯的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12241T1 (de) * 1981-03-03 1985-04-15 Lilly Industries Ltd Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4461775A (en) * 1982-08-02 1984-07-24 Mcneilab, Inc. Hydroxythioether fatty acid derivatives
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
US4552893A (en) * 1983-03-07 1985-11-12 Smithkline Beckman Corporation Leukotriene antagonists
US4533747A (en) * 1983-03-07 1985-08-06 Smithkline Beckman Corporation Leukotriene antagonists intermediates
DE3469169D1 (en) * 1983-04-21 1988-03-10 Merck Frosst Canada Inc Leukotriene antagonists, their production and use and compositions containing them
DE3582527D1 (en) * 1984-06-28 1991-05-23 Ciba Geigy Ag Aliphatische thioether.

Also Published As

Publication number Publication date
FI864901A (fi) 1987-06-07
EP0225602A2 (de) 1987-06-16
PT83868A (en) 1987-01-01
HU196173B (en) 1988-10-28
GR3003066T3 (en) 1993-02-17
DE3681890D1 (en) 1991-11-14
DK586186A (da) 1987-06-07
PT83868B (pt) 1989-07-31
ZA869213B (en) 1987-07-29
NO864896L (no) 1987-06-09
US4808572A (en) 1989-02-28
DK586186D0 (da) 1986-12-05
NO864896D0 (no) 1986-12-05
ES2040205T3 (es) 1993-10-16
JPS62138465A (ja) 1987-06-22
EP0225602A3 (en) 1989-06-14
CA1303294C (en) 1992-06-09
AU6613886A (en) 1987-06-11
EP0225602B1 (de) 1991-10-09
ATE68177T1 (de) 1991-10-15
FI864901A0 (fi) 1986-12-01
HUT43560A (en) 1987-11-30
IL80866A0 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
EP0228045B1 (de) Aromatische Thioether
EP1694318B1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum
US20090062372A1 (en) Glycopyrronium Salts and Their Therapeutic Use
PL154186B1 (en) Method for manufacturing arylic derivatives of the hydroxamic acid
EP0025192B1 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
EP0170048B1 (de) Aliphatische Thioether
EP0225602B1 (de) Alpha-Hydroxythioether
EP0029247B1 (de) Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3942729A1 (de) Capsaicin-derivate
EP0335315B1 (de) Neue Alkanophenone
EP0539329A1 (de) Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
DE202012011888U1 (de) Kristallines Mehrkomponentensystem von Rosuvastatin-Calciumsalz und Vanillin
EP0455596B1 (de) Substituierte Indole
DD211552A5 (de) Verfahren zur herstellung von benzamidoverbindungen
DE3326164A1 (de) Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DD295846A5 (de) Verfahren zur herstellung weiterer neuer alkanophenone
DD243697A5 (de) Aliphatische thioether
DD261149A5 (de) Verfahren zur herstellung neuartiger unsymmetrischer thioehter
DD275865A5 (de) Verfahren zur herstellung neuer cysteinderivate
EP0419411A2 (de) Zusätzliche weitere neue Alkanophenone
DD283617A5 (de) Verfahren zur herstellung neuer alkanophenone
DE2356830A1 (de) 1,4,7,10-tetrahydro-4,7-dioxo-12hcyclopentadichinolin-2,9-dicarbonsaeurederivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE60205035T2 (de) Zur behandlung von autoimmunerkrankungen und allergien geeignete sulfonderivate
DE2125113C3 (de) Bis-(4-chlorphenoxy)-essigsäure-(Nmethyl-pyrrolidyl-2)-methylester und dessen Säureanlagerungssalze, Verfahren zu seiner Herstellung sowie diesen enthaltende Arzneimittel
EP0643045A1 (de) Chinolin-Verbindungen als Leukotriene Antagonisten